ReviewFrontiers in genetics2022

Improving PARP inhibitor efficacy in high-grade serous ovarian carcinoma: A focus on the immune system.

Nirashaa T Bound et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.